Flash Sterilization of Implants and Surgical Instruments: Clinical Effectiveness and Guidelines (Last Updated: Jul 2, 2019)
Project Line:
Reference List
Current Filters
No filters applied.
Repetitive Transcranial Magnetic Stimulation for Patients with Depression: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines – An Update (Last Updated: Jun 28, 2019)
Project Line:
Health Technology Review
Interventions for the Diagnosis of Clostridioides Difficile: Clinical Effectiveness and Guidelines (Last Updated: Aug 2, 2019)
Project Line:
Reference List
Sugammadex for the Reversal of Neuromuscular Blockade in Surgical Patients: A Review of Clinical Effectiveness and Cost-Effectiveness (Last Updated: Aug 6, 2019)
Project Line:
Health Technology Review
tezacaftor/ivacaftor (Symdeko) (Last Updated: Aug 15, 2019)
Project Line:
Reimbursement Review
Project Status:
Not filed
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Symdeko
Manufacturer:
Vertex Pharmaceuticals Canada Inc.
Submission Type:
Non Submission
Indications:
Cystic fibrosis, F508del mutation(s)
eltrombopag (Revolade ) (Last Updated: Aug 15, 2019)
Project Line:
Reimbursement Review
Project Status:
Not filed
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Revolade
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Submission Type:
Non Submission
Indications:
Severe aplastic anemia
ibrutinib (Imbruvica) (Last Updated: Aug 15, 2019)
Project Line:
Reimbursement Review
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Imbruvica
Manufacturer:
Janssen Canada Inc.
Submission Type:
Non Submission
Indications:
Chronic graft versus host disease
vilazodone (Viibryd) (Last Updated: Aug 15, 2019)
Project Line:
Reimbursement Review
Project Status:
Not filed
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Viibryd
Manufacturer:
Allergan Inc.
Submission Type:
Non Submission
Indications:
Depression, Major depressive disorder
caplacizumab (Cablivi) (Last Updated: Nov 2, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Cablivi
Manufacturer:
Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
Submission Type:
Initial
Indications:
Indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PE) and immunosuppressive therapy.
Lipid Formulations for Patients Requiring Parenteral Nutrition: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines – An Update (Last Updated: Aug 2, 2019)
Project Line:
Health Technology Review